Diphtheria Vaccine Comprehensive Study by Type (DTaP, DT, Td, Tdap), Application (Childrens, Adolescents and Adults), End User (Hospitals, Clinics, Others) Players and Region - Global Market Outlook to 2028

Diphtheria vaccine are used for prevention of diphtheria diseases that caused by bacteria called as Corynebacterium diphtheria. Diphtheria vaccine market is expected to mark significant growth over forecasted period owing to increasing consumers spending on injection, that providing tetanus toxoid and pertussis vaccine for babies, children and adults. There has been significant rise in number of people using vaccines rather than traditional vaccine, where death rate of children fell from an estimated 9.6 million in 2000 to 7.6 million in 2010 in global, the future for diphtheria vaccine looks promising. The major companies are adding more proven technologies systematically and strategically in Asia-Pacific countries as these countries are focused on fastest-growing verticals in the healthcare sector.

Attributes	Details
Study Period	2018-2028
Base Year	2022
High Growth Market	Asia Pacific
Unit	Value (USD Million)

In diphtheria vaccine market, it has been observed that most of the companies are strengthen or introducing immunization programmes that provides more life-saving vaccines to people around the world and serving as a point of contact for other health needs such as deworming, vitamins and other services. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Diphtheria Vaccine market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Sanofi Pasteur (France), GlaxoSmithKline (United Kingdom), Bharat Biotech (India), Merck (United States), Novartis (Switzerland), Johnson & Johnson (United States), Bionet- Asia (Thailand) and Mass Biologics (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Meiji Holdings Co. (Japan) and Others.

AMA Research has segmented the market of Global Diphtheria Vaccine market by Type (DTaP, DT, Td and Tdap), Application (Childrens and Adolescents and Adults) and Region.



On the basis of geography, the market of Diphtheria Vaccine has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2022. Europe, on the other hand, stood as the second largest market due to the presence of key companies in the region and high technological advancement. If we see Market by End User, the sub-segment i.e. Hospitals will boost the Diphtheria Vaccine market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Increasing demand of diphtheria vaccine at Asia- Pacific regions. and Product innovation at developed and developing countries

Prevalence of Chronic Diseases. and Increasing Awareness among the Population Fuelled up the Vaccine Market.

Limitation due to Product Recalls are Anticipated to Challenge the Market.

High Cost Associated with Diphtheria Vaccines. and Skilled Pharmacist Required for Vaccination.

Proliferation due to High Birth Rate Leads to Grow the Diphtheria Vaccine Market. and Upsurge Demand for Prevention of Diseases such as Tetanus, Pertussis and Others.

In August 2022, GSK, announced it has completed the acquisition of Affinivax, a clinical-stage biopharmaceutical company based in Cambridge (Boston, Massachusetts). Affinivax has pioneered the development of a novel class of vaccines.
In September 2020, Sanofi Pasteur India, launched of Tetraxim. The booster vaccine indicated for preschoolers and provides protection against four major diseases diphtheria, tetanus, pertussis and polio. tetraxim combines four vaccines into one, reducing the number of injections, increasing comfort and improving vaccination compliance for Children and reducing parental anxiety.
“According to U.S. regulation, its deprived Progress in vaccine regulation globally that includes shifts towards strictly defined procedures for vaccine consistency, reliance on Good Manufacturing Practices (GMPs) rather than final product testing and continued vaccine pharmacovigilance and impact Surveillance. The systematic collection, analysis, interpretation, and dissemination of health data on an ongoing basis, to gain knowledge of the pattern of disease occurrence and potential in a community, in order to control and prevent disease in the community. rather than individual, sporadic field studies.”

Diphtheria Vaccine Manufacturers, Diphtheria Vaccine Traders, End-Use Market Participants of Different Segments of Diphtheria Vaccine, Government and Research Organizations, R&D Institutions and Others

To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.